Last: | $193.02 |
---|---|
Change Percent: | 0.02% |
Open: | $193.01 |
Close: | $193.02 |
High: | $193.38 |
Low: | $191.64 |
Volume: | 10,732,573 |
Last Trade Date Time: | 05/08/2020 04:47:25 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$193.02 | $193.01 | $193.02 | $193.38 | $191.64 | 10,732,573 | 05-08-2020 |
$192.99 | $195.17 | $192.99 | $195.31 | $192.47 | 7,415,411 | 05-07-2020 |
$193.89 | $194.9 | $193.89 | $196.45 | $193.68 | 9,945,689 | 05-06-2020 |
$192.78 | $190 | $192.78 | $193.73 | $189.2 | 3,608,174 | 05-05-2020 |
$188.7 | $190.46 | $188.7 | $190.46 | $187.75 | 2,246,952 | 05-04-2020 |
$189.74 | $187.79 | $189.74 | $189.99 | $186.18 | 5,787,032 | 05-01-2020 |
$187.34 | $188.41 | $187.34 | $188.86 | $186.94 | 3,284,792 | 04-30-2020 |
$189.29 | $187.72 | $189.29 | $190.03 | $186.85 | 4,151,632 | 04-29-2020 |
$187.35 | $188.87 | $187.35 | $189.41 | $186.45 | 4,612,820 | 04-28-2020 |
$188.24 | $187.04 | $188.24 | $188.57 | $187.04 | 3,416,470 | 04-27-2020 |
$186.9 | $186.52 | $186.9 | $186.93 | $185.09 | 4,297,940 | 04-24-2020 |
$185.55 | $185.92 | $185.55 | $187.09 | $185.23 | 3,316,686 | 04-23-2020 |
$185.34 | $185.36 | $185.34 | $186.74 | $185.16 | 6,238,074 | 04-22-2020 |
$184.04 | $185.85 | $184.04 | $186.4 | $183.94 | 4,631,633 | 04-21-2020 |
$187.39 | $186.7 | $187.39 | $189.15 | $185.88 | 3,804,373 | 04-20-2020 |
$187 | $187.09 | $187 | $187.71 | $185.83 | 4,830,736 | 04-17-2020 |
$185.19 | $187.27 | $185.19 | $196.19 | $184.67 | 6,365,426 | 04-16-2020 |
$185.71 | $184 | $185.71 | $187.02 | $183.85 | 1,891,285 | 04-15-2020 |
$186.73 | $184.93 | $186.73 | $187.64 | $184.93 | 4,347,461 | 04-14-2020 |
$183.83 | $182.11 | $183.83 | $184.01 | $181.6 | 2,762,267 | 04-13-2020 |
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...